Venture Houston 2018
Skip Content

19 March 2018

News round up 19 March 2018

A round up of all the latest news on for our subscribers.

Author: Callum Cyrus, reporter

Ozdemir joins UCL Technology Fund

Tanel Ozdemir, an alumnus of UCL, has joined Albion Capital as an analyst of the UCL Technology Fund.

Japan clocks 2,093 spinouts

Biotech, healthcare and medical technology accounted for roughly one-third of the country’s more than 2,000 spinouts, with another third taken up by IT companies.

Voci talks about $8m series B

Carnegie Mellon spinout Voci will use the money to bolster sales and marketing activities.

OxSyBio constructs $13.9m round

IP Group and Parkwalk Advisors both took part in the round, which took regenerative medicine developer OxSyBio’s total funding to $18.3m.

Arcus arcs to $120m IPO

Cancer immunotherapy developer Arcus Biosciences will float at the top of its range, scoring an exit for Stanford University.

CFS lights $50m fuse

Commonwealth Fusion Systems, based on MIT research, has launched with $50m in initial capital from energy company Eni to develop fusion power.

TeraPore fabricates $6m series A

The capital will help push development of the Cornell University spinout's copolymer-based materials for nanofabrication.

Valley Growth closes $6m fund

Valley Growth Ventures, whose founding partners include Youngstown State University, has begun talks with a healthcare-focused startup that could result in its first investment.

WSU and Phytelligence sue each other

WSU has filed a lawsuit ordering Phytelligence to cease growing its patented apple tree, despite retaining equity in the spinout.

Morgan State lights up Cykloburn

Cykloburn, which is commercialising technology to produce electricity and heat from poultry farm litter, is the first spinout to emerge out of Morgan State University.

Helsinn goes On Target in $44m round

Purdue spinout On Target Laboratories has closed a series B round at $44m after an $11.1m extension featuring Helsinn.

Copyright Mawsonia Limited 2010. Please don´t cut articles from or the PDF and redistribute by email or post to the web without written permission.

  • Linkedin
  • Mail
  • Rssfeed